Citation

Huestis MP, Durk MR, Eigenbrot C, Gibbons P, Hunsaker TL, La H, Leung DH, Liu W, Malek S, Merchant M, Moffat JG, Muli CS, Orr CJ, Parr BT, Shanahan F, Sneeringer CJ, Wang W, Yen I, Yin J, Rudolph J, Siu M.: Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor. ACS Med Chem Lett, Volume 12 (5), 2021

Authors

Durk MR, Eigenbrot C, Gibbons P, Huestis MP, Hunsaker TL, La H, Leung DH, Liu W, Malek S, Merchant M, Moffat JG, Muli CS, Orr CJ, Parr BT, Rudolph J, Shanahan F, Siu M., Sneeringer CJ, Wang W, Yen I, Yin J

Journal

ACS Med Chem Lett

Year

2021

DOI

10.1021/acsmedchemlett.1c00063

PubMed

34055227

Machine-readable

REST APIRDF